159 related articles for article (PubMed ID: 15517324)
61. Relationship of prostate-specific antigen and prostate volume in Korean men with biopsy-proven benign prostatic hyperplasia.
Lee SE; Chung JS; Han BK; Moon KH; Hwang SI; Lee HJ; Choe G; Hong SK
Urology; 2008 Mar; 71(3):395-8. PubMed ID: 18342171
[TBL] [Abstract][Full Text] [Related]
62. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
Naslund MJ; Miner M
Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
[TBL] [Abstract][Full Text] [Related]
63. Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate.
Paick JS; Um JM; Kwak C; Kim SW; Ku JH
Urology; 2007 May; 69(5):859-63. PubMed ID: 17482922
[TBL] [Abstract][Full Text] [Related]
64. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
[TBL] [Abstract][Full Text] [Related]
65. Is there an association between cigarette smoking and gland size in benign prostatic hyperplasia?
Matzkin H; Cytron S; Simon D
Prostate; 1996 Jul; 29(1):42-5. PubMed ID: 8685054
[TBL] [Abstract][Full Text] [Related]
66. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
Giles GG; Severi G; Sinclair R; English DR; McCredie MR; Johnson W; Boyle P; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):549-53. PubMed ID: 12050096
[TBL] [Abstract][Full Text] [Related]
67. Benign prostatic hyperplasia: a review of its histogenesis and natural history.
Oesterling JE
Prostate Suppl; 1996; 6():67-73. PubMed ID: 8630233
[TBL] [Abstract][Full Text] [Related]
68. Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment.
Hoffmann R; Happle R
Eur J Dermatol; 2000; 10(5):410-7. PubMed ID: 10882953
[TBL] [Abstract][Full Text] [Related]
69. Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study.
Matilainen VA; Mäkinen PK; Keinänen-Kiukaanniemi SM
J Cardiovasc Risk; 2001 Jun; 8(3):147-51. PubMed ID: 11455846
[TBL] [Abstract][Full Text] [Related]
70. Finasteride, a Type 2 5alpha-reductase inhibitor, in the treatment of men with androgenetic alopecia.
Kaufman KD; Dawber RP
Expert Opin Investig Drugs; 1999 Apr; 8(4):403-15. PubMed ID: 15992088
[TBL] [Abstract][Full Text] [Related]
71. Patients with a large prostate show a higher prevalence of androgenetic alopecia.
Kaplan SA
J Urol; 2005 Nov; 174(5):1905. PubMed ID: 16217338
[No Abstract] [Full Text] [Related]
72. [Prevalence of benign hypertrophy of the prostate in Turkish men hospitalized in urology].
Oztürk A; Serel TA; Kosar A; Kecelioglu M
Prog Urol; 2000 Sep; 10(4):568-70. PubMed ID: 11064898
[TBL] [Abstract][Full Text] [Related]
73. Current understanding of androgenetic alopecia. Part I: etiopathogenesis.
Hoffmann R; Happle R
Eur J Dermatol; 2000 Jun; 10(4):319-27. PubMed ID: 10846263
[TBL] [Abstract][Full Text] [Related]
74. Cytopathological changes in early stages of benign prostatic hyperplasia upon exposure to sustained delivery of androgens.
Pollan MC; Benghuzzi HA; Tucci M
Biomed Sci Instrum; 2002; 38():15-20. PubMed ID: 12085593
[TBL] [Abstract][Full Text] [Related]
75. Enzymology of the hair follicle.
Hoffmann R
Eur J Dermatol; 2001; 11(4):296-300. PubMed ID: 11399533
[TBL] [Abstract][Full Text] [Related]
76. Improvement in androgenetic alopecia in 53-76-year-old men using oral finasteride.
Brenner S; Matz H
Int J Dermatol; 1999 Dec; 38(12):928-30. PubMed ID: 10632776
[TBL] [Abstract][Full Text] [Related]
77. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors.
Severi G; Sinclair R; Hopper JL; English DR; McCredie MR; Boyle P; Giles GG
Br J Dermatol; 2003 Dec; 149(6):1207-13. PubMed ID: 14674898
[TBL] [Abstract][Full Text] [Related]
78. Association of benign prostatic hyperplasia with male pattern baldness.
Oh BR; Kim SJ; Moon JD; Kim HN; Kwon DD; Won YH; Ryu SB; Park YI
Urology; 1998 May; 51(5):744-8. PubMed ID: 9610587
[TBL] [Abstract][Full Text] [Related]
79. The prevalence and types of androgenetic alopecia in Korean men and women.
Paik JH; Yoon JB; Sim WY; Kim BS; Kim NI
Br J Dermatol; 2001 Jul; 145(1):95-9. PubMed ID: 11453914
[TBL] [Abstract][Full Text] [Related]
80. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.
Prager N; Bickett K; French N; Marcovici G
J Altern Complement Med; 2002 Apr; 8(2):143-52. PubMed ID: 12006122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
